PulseExploreJournal ClubDebatesTrendingResearchersJournals
Instagram
HomeExploreJournal ClubTrending
Synapse
⌘+K
Synapse
August 26, 2024Neuro-Oncology31 citations

Toll-like receptor agonists promote the formation of tertiary lymphoid structure and improve anti-glioma immunity

View Full Paper
SSShaoping ShenYCYong CuiMLMingxiao Li

Key Points

Key points are not available for this paper at this time.

Abstract

Abstract Background Glioma, characterized by limited lymphocytic infiltration, constitutes an “immune-desert” tumor displaying insensitivity to various immunotherapies. This study aims to explore therapeutic strategies for inducing tertiary lymphoid structure (TLS) formation within the glioma microenvironment (GME) to transition it from an immune resistant to an activated state. Methods TLS formation in GME was successfully induced by intracranial administration of Toll-like receptor (TLR) agonists (OK-432, TLR2/4/9 agonist) and glioma antigens (i.c. αTLR-mix). We employed staining analysis, antibody neutralization, single-cell RNA sequencing (scRNA-Seq), and BCR/TCR sequencing to investigate the underlying mechanisms of TLS formation and its role in anti-glioma immunity. Additionally, a preliminary translational clinical study was conducted. Results TLS formation correlated with increased lymphocyte infiltration in GME and led to improved prognosis in glioma-bearing mice. In the study of TLS induction mechanisms, certain macrophages/microglia and Th17 displayed markers of “LTo” and “LTi” cells, respectively, interaction through LTα/β-LTβR promoted TLS induction. Post-TLS formation, CD4 + and CD8 + T cells but not CD19 + B cells contributed to anti-glioma immunity. Comparative analysis of B/T cells between brain and lymph node showed that brain B/T cells unveiled the switch from naïve to mature, some B cells highlighted an enrichment of class switch recombination (CSR)-associated genes, V gene usage, and clonotype bias were observed. In related clinical studies, i.c. αTLR-mix treatment exhibited tolerability, and chemokines/cytokines assay provided preliminary evidence supporting TLS formation in GME. Conclusions TLS induction in GME enhanced anti-glioma immunity, improved the immune microenvironment, and controlled glioma growth, suggesting potential therapeutic avenues for treating glioma in the future.

Ask AI
Helpful
Bookmark
Share
View Full Paper

Cite This Study

Shen et al. (2024) studied this question.

synapsesocial.com/papers/68e5adc8b6db6435875472cahttps://doi.org/10.1093/neuonc/noae167
Ask AI
Helpful
Bookmark
Share
View Full Paper

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Glioma-associated tertiary lymphoid structures are sites of lymphocyte clonal expansion and plasma cell formation2024 · 1 citations
  2. 2TMIC-57. Inducing tumor associated tertiary lymphoid structures using cellular therapy2025
  3. 3TMIC-64. Multiomic analyses for tumor microenvironment with tertiary lymphoid structures in glioblastoma2025
  4. 4Cellular and molecular events organizing the assembly of tertiary lymphoid structures in glioblastoma2024 · 2 citations
  5. 5TCF1+CD4+ T cells and microglia co-orchestrate tertiary lymphoid structures to enhance prognosis and immunotherapy in non-small cell lung cancer with brain metastases2026